Advertisement
Screener

ARTIVION, INC. (AORT) Overview

ARTIVION, INC. (AORT) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.28; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.03; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.13; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 0.03; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$19.10$23.15$28.07$34.03$41.25$50.022025-11-062026-11-06$9.51$13.25$18.47$25.75$35.89$50.022021-11-082026-11-06$9.51$13.25$18.47$25.75$35.88$50.012016-11-072026-11-06$3.80$6.42$10.86$18.35$31.03$52.452006-11-062026-11-06$1.59$3.19$6.43$12.94$26.05$52.451993-02-122026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$20.21
Previous close
$22.86
Change
-$2.65
Change (%)
-11.59%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

AORT
-49.86%
S&P 500
(m)

1 year

AORT
-45.61%
S&P 500
(m)

3 years

AORT
+50.83%
S&P 500
(m)

5 years

AORT
+0.59%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.28

-0.36-0.19-0.030.140.3131 Mar 2025: estimate (m); actual -0.0131 Mar 2025(m)30 Jun 2025: estimate (m); actual 0.0330 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.1330 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.0331 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.2830 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.28(m)(m)
1 Jan 202631 Mar 2026(m)0.03(m)(m)
1 Jul 202530 Sept 2025(m)0.13(m)(m)
1 Apr 202530 Jun 2025(m)0.03(m)(m)
1 Jan 202531 Mar 2025(m)-0.01(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 0.21

-0.83-0.52-0.220.090.3931 Dec 2021: estimate (m); actual -0.3831 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.4831 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.7531 Dec 2023(m)31 Dec 2024: estimate (m); actual -0.3231 Dec 2024(m)31 Dec 2025: estimate (m); actual 0.2131 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)0.21(m)(m)
1 Jan 202431 Dec 2024(m)-0.32(m)(m)
1 Jan 202331 Dec 2023(m)-0.75(m)(m)
1 Jan 202231 Dec 2022(m)-0.48(m)(m)
1 Jan 202131 Dec 2021(m)-0.38(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 125.76M ■ Earnings -13.51M — Profit margin -10.74%

-30.22M-11.7%27.34M-5.6%84.91M0.6%142.47M6.7%30 Sept 2025: revenue 113.39M; earnings 6.50M; profit margin 5.73%30 Sept 202531 Dec 2025: revenue 115.99M*; earnings 2.43M*; profit margin 2.09%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 116.34M; earnings 1.42M; profit margin 1.22%31 Mar 202630 Jun 2026: revenue 125.76M; earnings -13.51M; profit margin -10.74%30 Jun 2026

31 Dec 2025 ■ Revenue 441.33M ■ Earnings 9.77M — Profit margin 2.21%

-87.33M-9.7%107.77M-5.4%302.87M-1.1%497.97M3.2%31 Dec 2022: revenue 313.79M; earnings -19.19M; profit margin -6.12%31 Dec 202231 Dec 2023: revenue 354.00M; earnings -30.69M; profit margin -8.67%31 Dec 202331 Dec 2024: revenue 388.54M; earnings -13.36M; profit margin -3.44%31 Dec 202431 Dec 2025: revenue 441.33M; earnings 9.77M; profit margin 2.21%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$20.21(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$20.21High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning AORT

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
637.35K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-5.32%*
Total return · month
-14.60%*
Total return · quarter
2.14%*
Total return · half year
-35.20%*
Total return · year to date
-49.86%*
Total return · 1 year
-45.61%*
Total return · 3 years
50.83%*
Total return · 5 years
0.59%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

ARTIVION, INC. Overview

View more →

(m)

(m)

SEC CIK
784199
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
1655 ROBERTS BOULEVARD N W, KENNESAW, Georgia, 30144, United States
Fiscal year end
1231
Phone
7704193355

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92